High-Impact Clinical Trials
October 23, 2020 | 10:30 AM - 12:30 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Oral Abstract Session
High-Impact Clinical Trials
October 23, 2020 | 10:30 AM - 12:30 PM
Location: Live-Streamed
Session Description
Presentation titles and authors will be available on October 9. Full abstracts will be available on October 25.
Learning Pathway(s)
Moderators
- Linda Awdishu, PharmD
- Deidra C. Crews, MD, MS, FASN
Presentations
- Effect of Finerenone on CKD Outcomes in Type 2 Diabetes
10:30 AM - 10:45 AM
George L. Bakris, MD, MA, FASN
George L. Bakris, MD, MA, FASN
Effect of Finerenone on CKD Outcomes in Type 2 Diabetes
October 23, 2020 | 10:30 AM - 10:45 AM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- EMPEROR-Reduced: Empagliflozin and Outcomes in Heart Failure and CKD
10:45 AM - 11:00 AM
Faiez Zannad, MD, PhD
EMPEROR-Reduced: Empagliflozin and Outcomes in Heart Failure and CKD
October 23, 2020 | 10:45 AM - 11:00 AM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Sequential Treatment with Tacrolimus and Rituximab vs. Alternating Corticosteroids and Cyclophosphamide in Primary Membranous Nephropathy (PMN)
11:00 AM - 11:15 AM
Gema Fernandez Juarez, MD, PhD
Gema Fernandez Juarez, MD, PhD
Sequential Treatment with Tacrolimus and Rituximab vs. Alternating Corticosteroids and Cyclophosphamide in Primary Membranous Nephropathy (PMN)
October 23, 2020 | 11:00 AM - 11:15 AM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Global Phase 3 Clinical Trials of Vadadustat vs. Darbepoetin Alfa for Treatment of Anemia in Patients with Non-Dialysis-Dependent CKD
11:15 AM - 11:30 AM
Glenn Matthew Chertow, MD, MPH, FASN
Glenn Matthew Chertow, MD, MPH, FASN
Global Phase 3 Clinical Trials of Vadadustat vs. Darbepoetin Alfa for Treatment of Anemia in Patients with Non-Dialysis-Dependent CKD
October 23, 2020 | 11:15 AM - 11:30 AM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Oral Intradialytic Nutritional Supplements and Mortality in Hemodialysis Patients: A Cluster-Randomized, Pragmatic Clinical Trial
11:30 AM - 11:45 AM
Daniel E. Weiner, MD, MS, FASN
Daniel E. Weiner, MD, MS, FASN
Oral Intradialytic Nutritional Supplements and Mortality in Hemodialysis Patients: A Cluster-Randomized, Pragmatic Clinical Trial
October 23, 2020 | 11:30 AM - 11:45 AM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Reducing the Burden of Dialysis Catheter Complications: A National Approach (REDUCCTION)
11:45 AM - 12:00 PM
Martin P. Gallagher, MBBS, PhD, MPH
Martin P. Gallagher, MBBS, PhD, MPH
Reducing the Burden of Dialysis Catheter Complications: A National Approach (REDUCCTION)
October 23, 2020 | 11:45 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Regional Citrate vs. Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy Among Critically Ill Patients with AKI: A Randomized Clinical Trial
12:00 PM - 12:15 PM
Alexander Zarbock, MD
Regional Citrate vs. Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy Among Critically Ill Patients with AKI: A Randomized Clinical Trial
October 23, 2020 | 12:00 PM - 12:15 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effects of Dapagliflozin on Kidney Function, Cardiovascular Events, and All-Cause Mortality According to Cause of Kidney Disease in the DAPA-CKD Trial
12:15 PM - 12:30 PM
David C. Wheeler, MD
Effects of Dapagliflozin on Kidney Function, Cardiovascular Events, and All-Cause Mortality According to Cause of Kidney Disease in the DAPA-CKD Trial
October 23, 2020 | 12:15 PM - 12:30 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
